EV/EBITDA
-0.54
0.000.00%
Wed, 26 Feb 2025 14:30:00 GMT
Summary
- As of February 27, 2025, NBY EV/EBITDA is -0.54, unchanged from the previous trading day.
- Over the past year, NBY EV/EBITDA has dropped by -0.29 (-116.00%).
- NBY EV/EBITDA is now -101.20% below its all-time high of 44.84.
Performance
NBY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NBY EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | +1.5% | +1.7% |
1 m1 month | +8.5% | -7.8% | -9.0% |
3 m3 months | -5.9% | +5.9% | +6.9% |
6 m6 months | +12.9% | -6.3% | +21.6% |
ytdytd | -3.9% | +4.3% | +5.1% |
1 y1 year | -116.0% | +197.3% | -87.3% |
5 y5 years | +65.2% | -75.6% | -99.9% |
NBY EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.59 | +8.5% | |
3 m | 3-month | -0.45 | -20.0% | -0.69 | +21.7% |
6 m | 6-month | -0.41 | -31.7% | -0.69 | +21.7% |
1 y | 1-year | -0.25 | -116.0% | -1.16 | +53.5% |
3 y | 3-year | 0.06 | -1000.0% | -1.71 | +68.4% |
5 y | 5-year | 0.06 | -1000.0% | -8.00 | +93.3% |
alltime | all time | 44.84 | -101.2% | -68.23 | +99.2% |
NovaBay Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -0.54(+3.8%) |
2024 | -0.52(+33.3%) |
2023 | -0.39(+333.3%) |
2022 | -0.09(-93.0%) |
2021 | -1.28(-54.1%) |
2020 | -2.79(+73.3%) |
2019 | -1.61(+22.0%) |
2018 | -1.32(-83.1%) |
2017 | -7.79(+106.6%) |
Date | Value |
---|---|
2016 | -3.77(+1156.7%) |
2015 | -0.30(-81.7%) |
2014 | -1.64(-45.9%) |
2013 | -3.03(-16.1%) |
2012 | -3.61(-50.7%) |
2011 | -7.32(+2.4%) |
2010 | -7.15(-155.9%) |
2009 | 12.79(-1131.5%) |
2008 | -1.24(-90.0%) |
2007 | -12.38 |
FAQ
- What is NovaBay Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for NovaBay Pharmaceuticals?
- What is NBY EV/EBITDA year-to-date change?
- What is NovaBay Pharmaceuticals EV/EBITDA year-on-year change?
What is NovaBay Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of NBY is -0.54
What is the all time high EV/EBITDA for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high EV/EBITDA is 44.84
What is NBY EV/EBITDA year-to-date change?
NovaBay Pharmaceuticals EV/EBITDA has changed by -0.02 (-3.85%) since the beginning of the year
What is NovaBay Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, NBY EV/EBITDA has changed by -0.29 (-116.00%)